This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

First Published Papers On IMRIS Suites Report Positive Results

Stocks in this article: IM IMRS

WINNIPEG, Sept. 26, 2011 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that the first published results on the early clinical experiences at hospitals using the IMRIS system, highlight a number of positive findings for procedures and patient outcomes resulting from utilization of the intraoperative MRI capabilities available in IMRIS suites.

The studies which were conducted at hospitals in three different countries each concluded that the IMRIS system can be safely integrated into neurosurgical workflows and enable intraoperative modification of surgical strategy in a range of neurosurgical procedures.

The studies included 180 patients treated from April 2008 to July 2009 at the Washington University School of Medicine in St. Louis, Missouri, USA (Chicoine MR., et al); 45 patients treated between July 2008 and July 2009 at PLA 301 Hospital in Beijing, China, ( Xiaolei Chen, et al); and 120 patients who underwent procedures between January 2009 and November 2009 at University of Calgary Foothills Hospital in Calgary, Alberta, Canada, ( Michael J. Lang, et al).

Highlights include:

  • In 41% of all cases in the Washington University School of Medicine study and in 48.9% of all cases included in the study at PLA 301 Hospital, the surgeon modified the surgical procedure based upon the intraoperative MR imaging information provided by the IMRIS suite.
  • Gross/near total tumor resection was achieved in 93% of patients with gliomas in the Washington University School of Medicine study, compared with 65% for procedures that did not utilize the intraoperative MR imaging capabilities in the same timeframe.
  • Gross/near total tumor resection was achieved in 76.9% of the pituitary adenoma procedures in the PLA 301 Hospital preliminary clinical experience which compared with 38.5% of the procedures having achieved gross/near total tumor resection prior to the intraoperative MR imaging.
  • From clinical experience with 120 patients, the University of Calgary Foothills Hospital study found that intraoperative imaging resulted in modification to surgery in a substantial number of patients and concluded that intraoperative imaging at 3.0T is safe, reliable and capable of directing image guided surgery with exceptional image quality.

Links to Abstracts for the studies referenced in this news release are available at the U.S. National Library of Medicine National Institutes of Health database website:

Globally, more than 6,000 procedures have now been completed in IMRIS suites which are designed to provide timely imaging information to assist clinicians in making better decisions for improved patient outcomes.  IMRIS suites allow a high field MR scanner to move into an operating room on demand before, during and after procedures without moving the patient.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs